Excellent outcome of medical treatment for Kasabach-Merritt syndrome: a single-center experience
Jin-Ah KIM; Young-Bae CHOI; Eun-Sang YI; Ji-Won LEE; Ki-Woong SUNG; Hong-Hoe KOO; Keon-Hee YOO.
Blood Research
; : 256-260, 2016.
Artículo en Inglés | WPRIM | ID: wpr-167170
Documentos relacionados
Kasabach-Merritt Syndrome: a case study of successful treatment with vincristine and propranolol.
[Clinical features of Kasabach-Merritt syndrome: an analysis of 16 neonates].
Reactivation of Kasabach-Merritt phenomenon in a young adult with a congenital kaposiform hemangioendothelioma.
Sirolimus plus prednisolone vs sirolimus monotherapy for kaposiform hemangioendothelioma: a randomized clinical trial.
Treatment practices and response in kaposiform hemangioendothelioma: A multicenter cohort study.
Targeting inflammation-induced Kasabach-Merritt phenomenon.
Cost and effectiveness comparison of sirolimus versus standard treatment in Kasabach-Merritt phenomenon: a real-world evidence study in Thailand.
Long-term outcomes of sirolimus treatment for kaposiform hemangioendothelioma: Continuing successes and ongoing challenges.
Effective surgical treatment of life-threatening huge vascular anomalies associated with thrombocytopenia and coagulopathy in infants unresponsive to drug therapy.
Kaposiform hemangioendothelioma presented with raynaud phenomenon: a case report.